Toronto, Ontario — Nutritional High International Inc. (CSE: EAT) (OTCQB: SPLIF) (FSE: 2NU) (“Nutritional High” or the “Company“) is pleased to announce that Kruzo LLC (“Kruzo“) has formed Psychedelic Science Corp to facilitate its previously announced acquisition by the Company on June 1, 2020. Psychedelic Science Corp. (“PSC“), a company registered in Ontario, will be the parent company of Kruzo and will raise approximately $1.5 million CAD prior to being acquired by Nutritional High.

Psychedelic Science Corp is formed with the mission of, “Assimilation of IP portfolio, product development and commercialization of health benefits derived from naturally occurring psychedelic compounds. Core focus areas will be Mental Ailments such as anxiety, depression and addiction together with Obesity using Peyote (cactai) as a primary solution and Psilocybin (mushrooms) as a secondary solution.”

The Company is also pleased to announce the appointment of the following as part of PSC’s senior management:

Dr. Duke Fu, President

Dr. Fu has a Doctor of Pharmacy and MBA from University of New Mexico and is one of the few Board Certified Nuclear Pharmacists (BCNP) in the state of Nevada. During his doctoral program, Dr. Fu studied and experimented with mycology, cultivating thirty species of fungi, including eight Psilocybin containing strains. He is also the co-founder and current CEO of Green Therapeutics, a premier cannabis cultivation and manufacturing company operating in Nevada since 2015.

As disclosed in previous filings, Nutritional High has an agreement to acquire 75% of Green Therapeutics. The agreement remains in place and the closing of the acquisition is pending the lift of the moratorium on cannabis license transfers in the State of Nevada.

Somnuek Suchaitanavanit, Head of Product and R&D

Mr. Suchaitanavanit is a Senior Advisor at the Department of Thai Traditional and Alternative Medicine, in the Ministry of Public Health. He also serves on the panel of directors that certify herbal Thai products for the Thai Food and Drug Administration. Mr. Suchaitanavanit is also a former Director of the Office of Thai Cannabis Pharmacists and led the program to legalize THC for medical purposes and CBD products for recreational use in Thailand.

Psychedelic Science Corp is also in the process of finalizing the candidate for the role of Chairman of the Medical Advisory Board with demonstrated experience in plant-based research.

John Durfy, CEO of Nutritional High commented, “We are deeply intrigued with the opportunities that both Peyote and Psilocybin presents for Psychedelic Science Corp and Nutritional High. The formation of Psychedelic Sciences Corp and the appointment of two extremely strong management team members completes an immediate milestone in our overall strategy in this space. Dr. Fu and Mr. Suchaitanavanit are highly respected scientific professionals in their fields. Simultaneously, they all have proven business expertise in new ventures and major program management, which will prove to be invaluable for PSC.”